Osaic Holdings’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Osaic Holdings’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,469	Closed	-$65K	–	7833
2022 Q1	$65K	Buy	3,469 +238	+7%	+$4.28K	﹤0.01%	4909
2021 Q4	$68K	Buy	3,231 +107	+3%	+$2.11K	﹤0.01%	4906
2021 Q3	$58K	Buy	3,124 +424	+16%	+$8.54K	﹤0.01%	4994
2021 Q2	$58K	Buy	2,700 +200	+8%	+$4.07K	﹤0.01%	4942
2021 Q1	$48K	Buy	+2,500	New	+$44.1K	﹤0.01%	4917

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Osaic Holdings's OCDX Position: Q2 2022 in Review

Osaic Holdings sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 3,469 shares — an estimated $65K sold.

Osaic Holdings first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $68K in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Osaic Holdings reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Osaic Holdings sold 3,469 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $65K.
Osaic Holdings first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
Osaic Holdings's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $68K in Q4 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Osaic Holdings's 13F filing for Q2 2022, filed 10 Aug 2022.